Skip to main content
Ciech S.A. logo

Ciech S.A. — Investor Relations & Filings

Ticker · CIE ISIN · PLCIECH00018 LEI · 259400GYHYZPQ0HTMT82 WAR Manufacturing
Filings indexed 1,285 across all filing types
Latest filing 2023-03-10 AGM Information
Country PL Poland
Listing WAR CIE

About Ciech S.A.

https://ciechgroup.com/en/

Qemetica (formerly Ciech S.A.) is a leading European chemical company with a global presence across multiple business segments. Its core business is Soda, producing soda ash for the glass industry and baking soda for the food and pharmaceutical sectors, ranking as the second-largest manufacturer in the European Union. The company is also a major producer of evaporated salt and salt tablets for water treatment. Other key segments include high-quality precipitated Silica for applications like modern tires, Agro Solutions featuring plant protection products, flexible Polyurethane Foams for the furniture industry, Silicates, and Glass packaging. Qemetica focuses on sustainable development and innovation, with products distributed across all continents.

Recent filings

Filing Released Lang Actions
Wniosek akcjonariusza o zwołanie Nadzwyczajnego Walnego Zgromadzenia - Content (EN)
AGM Information Classification · 1% confidence The document explicitly states that the Management Board received a letter from shareholders requesting to convene an Extraordinary General Meeting of Shareholders (EGM). It further mentions enclosing the request and draft resolutions. This content directly relates to the process of calling a shareholder meeting, which is often associated with proxy materials or the meeting itself. Since the text is about the *request* to convene a meeting and the materials related to it, and not the final voting results (DVA) or the AGM presentation itself (AGM-R), it fits best under the general category of materials related to shareholder meetings or governance. However, given the options, the request to convene a meeting is a precursor to the meeting itself. If the document were the final notice asking for votes, it would be PSI. Since it is an announcement about the *request* to hold a meeting, and it involves shareholder action regarding a meeting, it is closely related to shareholder communication. Given the short length (1129 chars) and the nature of announcing a request for a meeting, it is not a full report. It is an announcement concerning shareholder governance. Since there is no specific code for 'Request to Convene EGM', I must choose the closest fit. It is not a standard regulatory filing (RNS) as it is highly specific. It is not a DEF 14A (Remuneration) or DIRS (Director Dealing). It is most closely related to the governance and shareholder meeting process. Given the options, and the focus on convening a meeting, it is a specific corporate governance announcement. Since it is an announcement about a shareholder meeting request, and not the final voting results (DVA), the most appropriate general category for specific corporate governance actions that aren't standard reports is often RNS, but let's re-evaluate. The content is about the mechanics of calling a shareholder meeting. This is a key governance event. If this were the final notice to shareholders soliciting votes, it would be PSI. Since it is the announcement of the *request* to hold the meeting, it is a specific corporate action announcement. Given the lack of a perfect fit, and its nature as a formal announcement regarding shareholder rights/meetings, RNS (Regulatory Filings/Miscellaneous Announcement) is a safe fallback, but let's check if it fits better elsewhere. It is not an ER, IR, or 10-K. It is not a management change (MANG). It is a formal notice regarding a shareholder meeting. In many databases, such notices fall under general regulatory announcements or governance filings. Given the specific nature, and the fact that it is an announcement of a corporate event, RNS is the most appropriate catch-all for specific, non-standard announcements. However, if we consider the context of shareholder meetings, it is highly relevant to PSI (Proxy Solicitation & Information Statement), even if it precedes the actual solicitation. Since it is an announcement *about* the request, and not the solicitation itself, RNS is the most accurate classification for this specific type of regulatory disclosure.
2023-03-10 English
Wniosek akcjonariusza o zwołanie Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
AGM Information Classification · 1% confidence The document is a formal announcement from the Management Board of Ciech S.A. (Emitent) in Polish. It states that they received a request from a shareholder (KI Chemistry S.á r.l.) to convene an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) based on the Commercial Companies Code (art. 400 §1). The management board is forwarding this request and the proposed resolutions. This action—receiving and announcing a request to convene a shareholder meeting—is closely related to the process leading up to a General Meeting. While it is not the final AGM material (AGM-R) or the proxy solicitation (PSI), it is a direct regulatory announcement concerning a shareholder meeting request. Given the options, this type of corporate governance action announcement, which is not a standard financial report, dividend notice, or insider trade, fits best under the general regulatory announcement category, RNS, as it is a mandatory disclosure under market abuse regulations (Art. 17 MAR). However, since the core subject is the request for a General Meeting, and the document is short and serves as a notification of an attached request, it is a regulatory filing announcing a corporate governance event. RNS is the most appropriate fallback for specific corporate actions not covered elsewhere, especially when it's a short announcement of an attached document.
2023-03-10 Polish
Wezwanie do zapisywania się na sprzedaż akcji CIECH S.A. ogłoszone przez akcjonariusza KI Chemistry S.á r.l. - Content (EN)
M&A Activity Classification · 1% confidence The document explicitly discusses the announcement of a 'tender offer for shares of the Company' by a Shareholder, detailing the number of shares, the price, and the relevant legal framework (Public Offering Act). This clearly falls under the category of a proposal related to a takeover or acquisition activity. Based on the definitions, 'M&A Activity (Code: TAR)' is the most appropriate classification for announcements related to merger proposals or takeover bids (tender offers). The document is a direct announcement, not a report publication announcement (RPA).
2023-03-09 English
Wezwanie do zapisywania się na sprzedaż akcji CIECH S.A. ogłoszone przez akcjonariusza KI Chemistry S.á r.l. - Content (PL)
M&A Activity Classification · 1% confidence The document text is a formal announcement from the Management Board of Ciech S.A. regarding a mandatory tender offer ('Wezwanie') made by a major shareholder (KI Chemistry S.á r.l.) to acquire the remaining shares of the company, aiming for 100% ownership. This involves the acquisition of a significant stake (48.86% initially, aiming for full acquisition) through a public offer process governed by Polish public offering laws ('Ustawa o Ofercie Publicznej'). This clearly falls under the category of corporate actions related to mergers, acquisitions, or takeover bids. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER/MDA: Not an earnings release or management discussion. - CAP: While it involves financing/capital structure, the core event is a takeover bid/acquisition proposal. - TAR (M&A Activity): Defined as 'Announcements and documents related to merger proposals or takeover bids.' A tender offer ('Wezwanie') is a direct form of takeover bid. Therefore, the most appropriate classification is M&A Activity (TAR). The document length (2173 chars) is short, but it is the primary announcement of the event itself, not just an announcement *about* the publication of a report, making TAR more specific than RPA or RNS.
2023-03-09 Polish
Ujawnienie opóźnionej informacji poufnej dotyczącej udostępnienia KI Chemistry S.á r.l. oraz jej doradcom informacji o stanie Spółki oraz jej grupy kapitałowej oraz zawarcia umowy o zachowanie pouf...
Regulatory Filings Classification · 1% confidence The document explicitly references 'Regulation of the European Parliament and of the Council (EU) No. 596/2014 on Market Abuse (the Market Abuse Regulation)' (MAR) and discusses the delayed disclosure of 'inside information' regarding a 'potential transaction involving the Company's shares and obtaining financing or refinancing in connection therewith.' This structure, referencing MAR Article 17.4 regarding delayed disclosure of inside information, is characteristic of regulatory announcements made under EU market abuse rules, often related to potential M&A or significant corporate actions before they are finalized or publicly announced through other means. Since the core subject is a potential transaction (M&A/Financing) and it is a formal regulatory disclosure about inside information, it strongly aligns with either M&A Activity (TAR) or Capital/Financing Update (CAP). Given the context mentions 'potential transaction involving the Company's shares and obtaining financing or refinancing,' it is most closely related to a major corporate action announcement. However, the document itself is a formal notification about the *disclosure* of inside information concerning a potential transaction, which often falls under general regulatory reporting requirements when specific M&A or financing codes don't perfectly capture the nature of the disclosure itself. Since the content centers on a potential transaction (which could be M&A or financing), and it is a formal regulatory filing under MAR, it is best classified as a general Regulatory Filing (RNS) or potentially M&A Activity (TAR) if the transaction is clearly a takeover/merger. Given the ambiguity between financing and transaction, and the document being a formal notification of delayed inside information disclosure under MAR, RNS is a safe classification, but TAR covers 'merger proposals or takeover bids.' Since the text mentions 'potential transaction involving the Company's shares,' this often precedes a formal M&A announcement. Let's re-evaluate the options. It is not an ER, IR, 10-K, or CT. It is a specific regulatory disclosure about a potential transaction. If the transaction is a takeover/merger, TAR applies. If it's purely financing, CAP applies. Since the text mentions both shares and financing, and it is a formal MAR disclosure, RNS (Regulatory Filings) is the most appropriate general category for specific, non-standard regulatory disclosures that don't fit the primary financial report types, especially when the underlying event (the transaction) is still uncertain/potential. However, since the document is a formal, structured regulatory report detailing inside information about a potential transaction, and not just a brief announcement of a report, RNS is the best fit as a catch-all for specific regulatory notices not covered elsewhere, although TAR is a close second if the transaction is assumed to be M&A.
2023-02-13 English
Ujawnienie opóźnionej informacji poufnej dotyczącej udostępnienia KI Chemistry S.á r.l. oraz jej doradcom informacji o stanie Spółki oraz jej grupy kapitałowej oraz zawarcia umowy o zachowanie pouf...
Regulatory Filings Classification · 1% confidence The document text is written in Polish and explicitly references 'Zarząd Ciech S.A.' and 'art. 17 ust. 4 Rozporządzenia Parlamentu Europejskiego i Rady (UE) nr 596/2014' (MAR), which pertains to market abuse regulations and the delayed disclosure of inside information. The text describes the decision to provide documentation to a shareholder regarding a 'Potencjalna Transakcja' (Potential Transaction) and the justification for delaying the disclosure. This structure—a formal announcement regarding the delayed release of inside information under MAR—is characteristic of a mandatory regulatory filing in the EU/Poland. Since it is not a full annual report (10-K), an earnings release (ER), or a specific shareholder vote result (DVA), and it is a formal regulatory disclosure, the most appropriate general category for such mandatory, non-standardized regulatory announcements that don't fit other specific codes is 'Regulatory Filings' (RNS). The document is a 'raport bieżący' (current report) concerning inside information disclosure.
2023-02-13 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.